A new study involving teriparatide was published on October 26, 2026. The publication, titled "Teriparatide Topical Delivery Supports Osseointegration in Ovariectomized Rats Receiving Cafeteria Diet and Bisphosphonate: An In Vivo Experimental Study," appeared in Clinical Oral Implants Research.
The study is listed under PubMed ID 42931806. It is described as an in vivo experimental study examining topical delivery of teriparatide in an ovariectomized rat model, alongside a cafeteria diet and bisphosphonate exposure.
No findings, outcomes, or conclusions from the study have been provided beyond its title and publication details. This brief does not characterize or summarize any results, as none were included in the available event data.
Teriparatide remains an approved compound. Readers interested in background information can consult the compound overview for additional context on teriparatide.